Search Results - "Shams, Mahmood"

Refine Results
  1. 1

    Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors by Aslam, Muhammad Adil S., Mahmood, Shams-ul, Shahid, Mohammad, Saeed, Aamer, Iqbal, Jamshed

    Published in European journal of medicinal chemistry (01-11-2011)
    “…A series of new and novel Schiff base derivatives were synthesized and investigated as potential new inhibitors of Jack bean urease. The most potent compounds…”
    Get full text
    Journal Article
  2. 2

    Iminothiazoline-Sulfonamide Hybrids as Jack Bean Urease Inhibitors; Synthesis, Kinetic Mechanism and Computational Molecular Modeling by Saeed, Aamer, Mahmood, Shams-ul, Rafiq, Muhammad, Ashraf, Zaman, Jabeen, Farukh, Seo, Sung-Yum

    Published in Chemical biology & drug design (01-03-2016)
    “…The present work reports the synthesis of several 2‐iminothiazoline derivatives of sulfanilamide (3a–j) as inhibitors of jack bean ureases. The title compounds…”
    Get full text
    Journal Article
  3. 3

    Selective Removal of Lead (II) Ions from Wastewater with Fabricated ZnO-PVA Membrane by Rasheed, Hafiza Mehwish, Rauf, Abdul, Arif, Muhammad, Mohyuddin, Ayesha, Javid, Muhammad, Nadeem, Sohail, Yousuf, Afifa, Irfan, Muhammad, Haroon, Shah Muhammad, Raza, Hamid, Ibrahim, Sobhy M., Mahmood, Shams Ul

    Published in JOM (1989) (01-12-2023)
    “…Water contamination is a serious threat to living organisms and the contamination is increasing day by day due to versatile applications of heavy metal ions…”
    Get full text
    Journal Article
  4. 4

    Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors by Mahmood, Shams-ul, Saeed, Aamer, Bua, Sivia, Nocentini, Alessio, Gratteri, Paola, Supuran, Claudiu T.

    Published in Bioorganic chemistry (01-04-2018)
    “…[Display omitted] •The synthesis of a series of iminothiazolidinone benzenesulfonamides was reported.•The iminothiazolidinones were investigated as hCA I, II,…”
    Get full text
    Journal Article
  5. 5

    Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience by Rassoulzadegan, Maryam, Ala, Fereydoun, Jazebi, Mohammad, Enayat, Mohammad Said, Tabibian, Shadi, Shams, Mahmood, Bahraini, Mehran, Dorgalaleh, Akbar

    Published in International journal of hematology (01-04-2020)
    “…Type 2 von Willebrand disease (VWD) is the most common congenital bleeding disorder, with variable bleeding tendency and a complex laboratory phenotype. In the…”
    Get full text
    Journal Article
  6. 6

    Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Coumarinylthiazolyl Iminothiazolidinone Hybrids as Potent Urease Inhibitors by Mahmood, Shams‐Ul, Nazir, Yasir, Saeed, Aamer, Abbas, Qamar, Ashraf, Zaman

    Published in ChemistrySelect (Weinheim) (14-05-2020)
    “…The present paper is designed to explore the potential of an important class of heterocycles coumarinylthiazolyl iminothiazolidinone to inhibit jack bean…”
    Get full text
    Journal Article
  7. 7

    Discovery of isoxazolyl-based inhibitors of Plasmodium falciparum cGMP-dependent protein kinase by Mahmood, Shams Ul, Cheng, Huimin, Tummalapalli, Sreedhar R, Chakrasali, Ramappa, Yadav Bheemanaboina, Rammohan R, Kreiss, Tamara, Chojnowski, Agnieska, Eck, Tyler, Siekierka, John J, Rotella, David P

    Published in RSC medicinal chemistry (01-01-2020)
    “…The cGMP-dependent protein kinase in (PfPKG) plays multiple roles in the life cycle of the parasite. As a result, this enzyme is a potential target for new…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors by Iqbal, Jamshed, Saeed, Aamer, Shah, Syed J A, al-Rashida, Mariya, Shams-ul Mahmood

    “…In an attempt to discover novel anti-cancer agents and potent cholinesterase inhibitors, 11 azomethine-dihydroquinazolinone conjugates were evaluated against…”
    Get more information
    Journal Article
  10. 10

    Laboratory Diagnosis of Factor XIII Deficiency in Developing Countries: An Iranian Experience by Dorgalaleh, Akbar, Tabibian, Shadi, Shams, Mahmood, Tavasoli, Behnaz, Gheidishahran, Maryam, Shamsizadeh, Morteza

    Published in Laboratory medicine (01-08-2016)
    “…Factor XIII (FXIII) deficiency is an extremely rare bleeding disorder with an approximately 12-times higher than the rest of the world. The International…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Synthesis and Crystal Structure of 3-(4-Methoxyphenyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one by Saeed, Aamer, Mahmood, Shams ul, Ishida, H.

    Published in Crystals (Basel) (29-08-2011)
    “…Synthesis of the title compound from 4-methoxyaniline was accomplished in three steps. The structure was supported by spectroscopic data and unambiguously…”
    Get full text
    Journal Article
  13. 13

    Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement by Sayyadi, Mohammad, Hassani, Saeed, Shams, Mahmood, Dorgalaleh, Akbar

    Published in Annals of hematology (01-06-2023)
    “…The coagulation, fibrinolytic, anticoagulation, and complement systems are in delicate balance with the vessel wall endothelium ensuring appropriate…”
    Get full text
    Journal Article
  14. 14

    Cancer-associated thrombosis: the role of inherited thrombophilia by Zia, Anita, Shams, Mahmood, Dabbagh, Ali, Shahsavari, Milad, Dorgalaleh, Akbar

    Published in Blood coagulation & fibrinolysis (01-09-2024)
    “…Cancer-associated thrombosis (CAT) is a common complication and a major cause of morbidity and mortality in patients with active cancers. CAT is common in…”
    Get full text
    Journal Article
  15. 15

    Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients by Shams, Mahmood, Hassani, Saeed, Dorgalaleh, Akbar, Zamani, Fatemeh, Ahmadi, Abbas

    Published in Blood coagulation & fibrinolysis (01-04-2023)
    “…The congenital factor VII (FVII) deficiency with an estimated incidence of one per 300 000 is the most common rare congenital bleeding disorder. The…”
    Get full text
    Journal Article
  16. 16

    Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients by Shams, Mahmood, Hassani, Saeed, Dorgalaleh, Akbar, Zamani, Fatemeh, Ahmadi, Abbas

    Published in Blood coagulation & fibrinolysis (30-01-2023)
    “…The congenital factor VII (FVII) deficiency with an estimated incidence of one per 300 000 is the most common rare congenital bleeding disorder. The…”
    Get full text
    Journal Article
  17. 17

    Congenital Bleeding Disorders and COVID-19-A Systematic Literature Review by Dorgalaleh, Akbar, Safdari, Seyed Mehrab, Tabibian, Shadi, Shams, Mahmood, Dabbagh, Ali, Rezazadeh, Azadeh

    Published in Seminars in thrombosis and hemostasis (01-06-2024)
    “…Hypercoagulability is a prominent feature of coronavirus disease 2019 (COVID-19) and can lead to fatal consequences. Although the impact of COVID-19 on several…”
    Get more information
    Journal Article
  18. 18

    A Comprehensive Overview of Coagulation Factor V and Congenital Factor V Deficiency by Tabibian, Shadi, Shiravand, Yavar, Shams, Mahmood, Safa, Majid, Gholami, Mohammad Saeed, Heydari, Farshad, Ahmadi, Abbas, Rashidpanah, Jamal, Dorgalaleh, Akbar

    Published in Seminars in thrombosis and hemostasis (01-07-2019)
    “…Coagulation factor (F) V is a glycoprotein that plays an essential role in the formation of the prothrombinase complex, which is critical for progressing clot…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Falsely prolonged prothrombin time test in a patient with erythrocytosis: a case report by Aghajani Daronkola, Meysam, Dabbagh, Ali, Shams, Mahmood, Tabibian, Shadi, Hosseini, Soudabeh, Safdari, Seyed Mehrab, Dorgalaleh, Akbar

    Published in Blood coagulation & fibrinolysis (01-04-2024)
    “…The prothrombin time (PT) test is commonly used to monitor deficiencies in coagulation factors. A prolonged PT may indicate a deficiency of factors II, V, VII,…”
    Get full text
    Journal Article